Search - tctmd.com

Displaying 701 - 720 of 821

Sort: Relevancy | Date

News Industry News

St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve

December 12, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Conference News

Non-Primary PCI Can Be Performed Safely Without On-site Cardiac Surgery

November 14, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Industry News

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

November 10, 2011

News Industry News

Sunshine Heart sees positive results in heart pump trial

November 09, 2011

News Conference News

MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 Year

November 09, 2011

News Industry News

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

November 09, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Industry News

InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device

November 08, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Industry News

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

November 08, 2011

News Conference News

PAX Studies Highlight Polymer-Free DES Success

November 07, 2011

Advertisement

St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Non-Primary PCI Can Be Performed Safely Without On-site Cardiac Surgery

Paclitaxel-coated balloon angioplasty demonstrates superior results

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

CryoPlasty® Therapy With Boston Scientific PolarCath™ Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures

Sunshine Heart sees positive results in heart pump trial

MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 Year

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

Complications After TAVR: Manageable, But Important to Consider

PROTECT II: Positive Outcomes Observed with Impella Device

InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Low Event Rates with EES Sustained at 2 Years

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

PAX Studies Highlight Polymer-Free DES Success

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content